Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$191.17 - $325.63 $2.49 Million - $4.23 Million
13,000 Added 12.81%
114,500 $37.3 Million
Q4 2023

Feb 13, 2024

SELL
$160.99 - $215.69 $2.41 Million - $3.24 Million
-15,000 Reduced 12.88%
101,500 $19.3 Million
Q3 2023

Nov 13, 2023

SELL
$194.33 - $283.97 $388,660 - $567,940
-2,000 Reduced 1.69%
116,500 $23.2 Million
Q2 2023

Aug 11, 2023

BUY
$223.05 - $302.68 $111,525 - $151,340
500 Added 0.42%
118,500 $33.8 Million
Q1 2023

May 12, 2023

SELL
$175.41 - $217.92 $805,658 - $1 Million
-4,593 Reduced 3.75%
118,000 $25.6 Million
Q4 2022

Feb 13, 2023

SELL
$204.38 - $296.82 $2.08 Million - $3.02 Million
-10,182 Reduced 7.67%
122,593 $25.2 Million
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $27.8 Million - $44.2 Million
-142,225 Reduced 51.72%
132,775 $36.9 Million
Q2 2022

Aug 12, 2022

SELL
$115.91 - $214.48 $1.45 Million - $2.68 Million
-12,500 Reduced 4.35%
275,000 $52.6 Million
Q1 2022

May 13, 2022

BUY
$127.96 - $207.36 $20.9 Million - $33.8 Million
163,200 Added 131.3%
287,500 $59.6 Million
Q4 2021

Feb 11, 2022

BUY
$165.13 - $241.83 $330,260 - $483,660
2,000 Added 1.64%
124,300 $22.2 Million
Q3 2021

Nov 12, 2021

BUY
$163.99 - $235.57 $131,192 - $188,456
800 Added 0.66%
122,300 $25.2 Million
Q1 2021

May 14, 2021

SELL
$92.73 - $142.05 $1.25 Million - $1.92 Million
-13,500 Reduced 10.0%
121,500 $15.8 Million
Q4 2020

Feb 16, 2021

BUY
$67.44 - $103.72 $1.15 Million - $1.76 Million
17,000 Added 14.41%
135,000 $14 Million
Q3 2020

Nov 13, 2020

BUY
$42.79 - $75.8 $5.05 Million - $8.94 Million
118,000 New
118,000 $8.95 Million
Q1 2020

May 14, 2020

SELL
$23.16 - $47.74 $558,156 - $1.15 Million
-24,100 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$29.4 - $44.98 $708,540 - $1.08 Million
24,100 New
24,100 $1.06 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Atika Capital Management LLC Portfolio

Follow Atika Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.